Alyeska Investment Group’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-292,091
| Closed | -$304K | – | 677 |
|
|
2025
Q1 | $304K | Sell |
292,091
-566,992
| -66% | -$590K | ﹤0.01% | 477 |
|
|
2024
Q4 | $839K | Sell |
859,083
-60,930
| -7% | -$59.5K | ﹤0.01% | 502 |
|
|
2024
Q3 | $1.35M | Hold |
920,013
| – | – | 0.01% | 444 |
|
|
2024
Q2 | $1.24M | Hold |
920,013
| – | – | 0.01% | 428 |
|
|
2024
Q1 | $1.51M | Sell |
920,013
-121,318
| -12% | -$199K | 0.01% | 383 |
|
|
2023
Q4 | $2.01M | Buy |
1,041,331
+1,002,636
| +2,591% | +$1.94M | 0.01% | 348 |
|
|
2023
Q3 | $92.9K | Buy |
+38,695
| New | +$92.9K | ﹤0.01% | 450 |
|
|
2023
Q2 | – | Sell |
-38,695
| Closed | -$63.1K | – | 588 |
|
|
2023
Q1 | $63.1K | Sell |
38,695
-658,753
| -94% | -$1.07M | ﹤0.01% | 415 |
|
|
2022
Q4 | $1.91M | Sell |
697,448
-588,552
| -46% | -$1.61M | 0.02% | 321 |
|
|
2022
Q3 | $5.08M | Buy |
+1,286,000
| New | +$5.08M | 0.06% | 263 |
|
|
2018
Q3 | – | Sell |
-7,588
| Closed | -$1.14M | – | 478 |
|
|
2018
Q2 | $1.14M | Buy |
+7,588
| New | +$1.14M | 0.01% | 361 |
|